Author Question: Clients identified with hyperlipidemia postkidney transplant should be treated with a lipid-lowering ... (Read 45 times)

Garrulous

  • Hero Member
  • *****
  • Posts: 686
Clients identified with hyperlipidemia postkidney transplant should be treated with a lipid-lowering agent and a therapeutic diet to prevent:
 
  1. Hypertension.
   2. Peripheral neuropathy.
   3. Diabetes.
   4. Cardiovascular disease.

Question 2

To reduce the risk of aspiration, patients who are receiving enteral tube feedings should be positioned
 
  a. sitting upright.
  b. lying on their side.
  c. with the head of the bed elevated 30 to 45 degrees.
  d. with the head of the bed elevated 45 to 60 degrees.



Sarahjh

  • Sr. Member
  • ****
  • Posts: 370
Answer to Question 1

4

Rationale: Clients who are identified postkidney transplant to have hyperlipidemia should be treated with a lipid-lowering agent and a therapeutic diet to prevent cardiovascular disease. Hyperlipidemia is reported in about 90 of clients postkidney transplant. Hypertension, which may result from sodium retention caused as an adverse side effect of medications, may also contribute to cardiac risk along with diabetes. Peripheral neuropathy is not caused by hyperlipidemia.

Answer to Question 2

C
Patients who are receiving enteral tube feedings should be positioned with the head of the bed elevated 30 to 45 degrees to help prevent aspiration. They do not need to sit upright. Lying on their side does not reduce the risk of aspiration.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library